{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T22:13:38Z","timestamp":1790633618205,"version":"4.1.0"},"reference-count":27,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Br Dent J"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1038\/sj.bdj.2017.79","type":"journal-article","created":{"date-parts":[[2017,1,27]],"date-time":"2017-01-27T00:23:57Z","timestamp":1485476637000},"page":"121-125","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":52,"title":["Awareness of medication related osteonecrosis of the jaws (MRONJ) amongst general dental practitioners"],"prefix":"10.1038","volume":"222","author":[{"given":"N.","family":"Tanna","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C.","family":"Steel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S.","family":"Stagnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2017,1,27]]},"reference":[{"key":"BFsjbdj201779_CR1","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0278-2391(03)00328-8","volume":"61","author":"J Wang","year":"2003","unstructured":"Wang J, Goodger N M, Pogrel M A . Osteonecrosis of the jaw associated with cancer chemotherapy. J Oral Maxillofac Surg 2003; 61: 1104\u20131107.","journal-title":"J Oral Maxillofac Surg"},{"key":"BFsjbdj201779_CR2","unstructured":"Pazdur R . Postmarketing safety review: Bisphosphonates. Food and Drug Administration, Office of Drug Safety. Online document available at \n                    http:\/\/www.fda.gov\/ohrms\/dockets\/ac\/05\/briefing\/2005-4095b2_03_02-fda-tab1.doc\n                    \n                   (accessed January 2017)."},{"key":"BFsjbdj201779_CR3","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1503\/cmaj.050640","volume":"172","author":"E Wooltorton","year":"2005","unstructured":"Wooltorton E . Patients receiving intravenous bisphosphonates should avoid invasive dental procedures. CMAJ 2005; 172: 1684.","journal-title":"CMAJ"},{"key":"BFsjbdj201779_CR4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1308\/003588410X12699663903395","volume":"92","author":"ZH Baqain","year":"2010","unstructured":"Baqain Z H, Sawair F A, Tamimi Z et al. Osteonecrosis of jaws related to intravenous bisphosphonates: the experience of a Jordanian teaching hospital. Ann R Coll Surg Eng 2010; 92: 489\u2013494.","journal-title":"Ann R Coll Surg Eng"},{"key":"BFsjbdj201779_CR5","unstructured":"Bisphosphonates and other drugs affecting bone metabolism. In British National Formulary. 69th ed. p 513. 2014."},{"key":"BFsjbdj201779_CR6","unstructured":"European Medicines Agency. Further measures to minimise risk of osteonecrosis of the jaw with bisphosphonate EMA\/206916\/2015: 27 March 2015. Available online at \n                    http:\/\/www.ema.europa.eu\/docs\/en_GB\/document_library\/Press_release\/2015\/03\/WC500184865.pdf\n                    \n                   (accessed January 2017)."},{"key":"BFsjbdj201779_CR7","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.bone.2010.11.020","volume":"48","author":"R Baron","year":"2011","unstructured":"Baron R, Ferrari S, Russell R G . Denosumab and bisphosphonates: different mechanisms of action and effects. Bone 2011; 48: 677\u2013692.","journal-title":"Bone"},{"key":"BFsjbdj201779_CR8","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrd3705","volume":"11","author":"DL Lacey","year":"2012","unstructured":"Lacey D L, Boyle W J, Simonet W S et al. Bench to bedside: elucidation of the OPGRANKRANKL pathway and the development of denosumab. Nat Rev Drug Discov 2012; 11: 401\u2013419.","journal-title":"Nat Rev Drug Discov"},{"key":"BFsjbdj201779_CR9","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","volume":"19","author":"RG Russell","year":"2008","unstructured":"Russell R G, Watts N B, Ebetino F H et al. Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. Osteoporos Int 2008; 19: 733\u2013759.","journal-title":"Osteoporos Int"},{"key":"BFsjbdj201779_CR10","doi-asserted-by":"crossref","first-page":"6222s","DOI":"10.1158\/1078-0432.CCR-06-0843","volume":"12","author":"AJ Roelofs","year":"2006","unstructured":"Roelofs A J, Thompson K, Gordon S et al. Molecular mechanisms of action of bisphosphonates: current status. Clin Cancer Res 2006; 12: 6222s\u20136230s.","journal-title":"Clin Cancer Res"},{"key":"BFsjbdj201779_CR11","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S8756-3282(99)00116-7","volume":"25","author":"RG Russell","year":"1999","unstructured":"Russell R G, Rogers M J . Bisphosphonates: from the laboratory to the clinic and back again. Bone 1999; 25: 97\u2013106.","journal-title":"Bone"},{"key":"BFsjbdj201779_CR12","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.joms.2009.01.007","volume":"67","author":"MR Allen","year":"2009","unstructured":"Allen M R, Burr D B . The pathogenesis of bisphosphonate-related osteonecrosis of the jaw: so many hypotheses, so few data. J Oral Maxillofac Surg 2009; 67: 61.","journal-title":"J Oral Maxillofac Surg"},{"key":"BFsjbdj201779_CR13","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1749-6632.2010.05835.x","volume":"1218","author":"R Landesberg","year":"2011","unstructured":"Landesberg R, Woo V, Cremers S et al. Potential pathophysiological mechanisms in osteonecrosis of the jaw. Ann N Y Acad Sci 2011; 1218: 62\u201379.","journal-title":"Ann N Y Acad Sci"},{"key":"BFsjbdj201779_CR14","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S1532-3382(12)70046-5","volume":"12","author":"J Yamashita","year":"2012","unstructured":"Yamashita J, McCauley L K . Antiresorptives and osteonecrosis of the jaw. J Evid Based Dent Pract 2012; 12: 233\u2013247.","journal-title":"J Evid Based Dent Pract"},{"key":"BFsjbdj201779_CR15","unstructured":"Scottish Dental Clinical Effectiveness Programme. SDCEP Oral Health Management of Patients. 2011. Available online at \n                    http:\/\/www.sdcep.org.uk\/published-guidance\/bisphosphonates\n                    \n                   (accessed January 2017)."},{"key":"BFsjbdj201779_CR16","unstructured":"Faculty of General Dental Practice. National study on avascular necrosis of the jaws. 2012. Available at: \n                    http:\/\/www.fgdp.org.uk\/_assets\/pdf\/research\/final%20report-27.11.12.pdf\n                    \n                   (accessed January 2017)."},{"key":"BFsjbdj201779_CR17","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.1016\/j.joms.2014.04.031","volume":"72","author":"SL Ruggiero","year":"2014","unstructured":"Ruggiero S L, Dodson T B, Fantasia J et al. American Association of Oral and Maxillofacial Surgeons. American Association of Oral and Maxillofacial Surgeons position paper on medication related osteonecrosis of the jaw - 2014 update. J Oral Maxillofac Surg 2014; 72: 1938\u20131956.","journal-title":"J Oral Maxillofac Surg"},{"key":"BFsjbdj201779_CR18","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.joms.2009.03.050","volume":"68","author":"JC Lo","year":"2010","unstructured":"Lo J C, O'Ryan F S, Gordon N P et al. Prevalence of osteonecrosis of the jaw in patients with oral bisphosphonate exposure. J Oral Maxillofac Surg 2010; 68: 243\u2013253.","journal-title":"J Oral Maxillofac Surg"},{"key":"BFsjbdj201779_CR19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s00774-011-0299-z","volume":"30","author":"N Malden","year":"2012","unstructured":"Malden N, Lopes V . An epidemiological study of alendronate-related osteonecrosis of the jaws. A case series from the south-east of Scotland with attention given to case definition and prevalence. J Bone Miner Metab 2012; 30: 171\u2013182.","journal-title":"J Bone Miner Metab"},{"key":"BFsjbdj201779_CR20","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1002\/jbmr.1479","volume":"27","author":"S Papapoulos","year":"2012","unstructured":"Papapoulos S, Chapurlat R, Libanati C et al. Five years of denosumab exposure in women with postmenopausal osteoporosis: results from the first two years of the FREEDOM extension. J Bone Miner Res 2012; 27: 694\u2013701.","journal-title":"J Bone Miner Res"},{"key":"BFsjbdj201779_CR21","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.14219\/jada.archive.2010.0082","volume":"141","author":"JT Grbic","year":"2010","unstructured":"Grbic J T, Black D M, Lyles K W et al. The incidence of osteonecrosis of the jaw in patients receiving 5 milligrams of zoledronic acid: data from the health outcomes and reduced incidence with zoledronic acid once yearly clinical trials program. J Am Dent Assoc 2010; 141: 1365\u20131370.","journal-title":"J Am Dent Assoc"},{"key":"BFsjbdj201779_CR22","first-page":"403","volume":"19","author":"WX Qi","year":"2013","unstructured":"Qi W X, Tang L N, He A N et al. Risk of osteonecrosis of the jaw in cancer patients receiving denosumab: a meta-analysis of seven randomized controlled trials. Int J Clin Oncol 2013; 19: 403\u2013410.","journal-title":"Int J Clin Oncol"},{"key":"BFsjbdj201779_CR23","unstructured":"British Dental Association. The State of General Dental Practice in 2013. 2013. Available online at \n                    https:\/\/www.bda.org\/dentists\/policy-campaigns\/research\/workforce-finance\/ddrb\/Documents\/state_of_general_dental_practice_november_2013.pdf\n                    \n                   (accessed January 2017)."},{"key":"BFsjbdj201779_CR24","unstructured":"NHS England. Guide for Commissioning Oral Surgery and Oral Medicine. 2015. Available online at \n                    https:\/\/www.england.nhs.uk\/commissioning\/wp-content\/uploads\/sites\/12\/2015\/09\/guid-comms-oral.pdf\n                    \n                   (accessed February 2017)."},{"key":"BFsjbdj201779_CR25","unstructured":"MDDUS. MDDUS Dental membership continues to rise. Press release 2015. Available online at \n                    http:\/\/www.mddus.com\/media-centre\/press-releases\/2015\/november\/mddus-dental-membership-continues-to-rise\/\n                    \n                   (accessed January 2017)."},{"key":"BFsjbdj201779_CR26","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.2405","volume":"30","author":"AA Khan","year":"2015","unstructured":"Khan A A, Morrison A, Hanley D A et al. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res 2015; 30: 3\u201323.","journal-title":"J Bone Miner Res"},{"key":"BFsjbdj201779_CR27","doi-asserted-by":"crossref","first-page":"145","DOI":"10.4103\/0970-9185.155138","volume":"31","author":"E Moka","year":"2015","unstructured":"Moka E, Argyra E, Siafaka I, Vadalouca A . Chlorhexidine: Hypersensitivity and anaphylactic reactions in the perioperative setting. J Anaesthesiol Clin Pharmacol 2015; 31: 145\u2013148.","journal-title":"J Anaesthesiol Clin Pharmacol"}],"container-title":["British Dental Journal"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/sj.bdj.2017.79.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/sj.bdj.2017.79","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/sj.bdj.2017.79.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,20]],"date-time":"2023-05-20T18:34:29Z","timestamp":1684607669000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/sj.bdj.2017.79"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["BFsjbdj201779"],"URL":"https:\/\/doi.org\/10.1038\/sj.bdj.2017.79","relation":{},"ISSN":["0007-0610","1476-5373"],"issn-type":[{"value":"0007-0610","type":"print"},{"value":"1476-5373","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"31 October 2016","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"27 January 2017","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}]}}